14.71
price down icon0.61%   -0.09
after-market アフターアワーズ: 14.71
loading

Travere Therapeutics Inc (TVTX) 最新ニュース

pulisher
Jun 17, 2025

(TVTX) On The My Stocks Page - news.stocktradersdaily.com

Jun 17, 2025
pulisher
Jun 17, 2025

Rhumbline Advisers Grows Stock Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX) - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

What is HC Wainwright’s Estimate for TVTX Q2 Earnings? - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere ... - Eagle-Tribune

Jun 15, 2025
pulisher
Jun 15, 2025

Travere Therapeutics Launches "Play It Forward" Campaign to Celebrate the FSGS Community on Inaugural Awareness Day - Black Hills Pioneer

Jun 15, 2025
pulisher
Jun 14, 2025

HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs - MSN

Jun 14, 2025
pulisher
Jun 14, 2025

Leerink Partnrs Has Negative Outlook for TVTX Q4 Earnings - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Travere Therapeutics’ SWOT analysis: rare disease stock faces regulatory hurdles - Investing.com Canada

Jun 13, 2025
pulisher
Jun 13, 2025

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | TVTX Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Citigroup Issues Pessimistic Forecast for Travere Therapeutics (NASDAQ:TVTX) Stock Price - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Travere Therapeutics (NASDAQ:TVTX) Stock Rating Upgraded by HC Wainwright - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 12, 2025 - BioSpace

Jun 13, 2025
pulisher
Jun 13, 2025

10 Best Growth Stocks Under $100 to Buy Now - Insider Monkey

Jun 13, 2025
pulisher
Jun 12, 2025

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Travere Therapeutics Inc (TVTX) Has Recovered 53.17% From Its Low: Is This The Beginning Of A Trend? - Stocksregister

Jun 12, 2025
pulisher
Jun 12, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc.TVTX - WV News

Jun 12, 2025
pulisher
Jun 11, 2025

Travere Therapeutics (TVTX) Price Target Lowered by Citigroup | - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Citi Adjusts Price Target and Maintains Buy Rating on Travere Th - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Travere Therapeutics (TVTX) Price Target Lowered by Citigroup | TVTX Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Travere Therapeutics (TVTX) Receives Buy Rating from HC Wainwrig - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Travere Therapeutics (TVTX) Receives Buy Rating from HC Wainwright & Co. | TVTX Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

7 Analysts Assess Travere Therapeutics: What You Need To Know - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 15th International Podocyte Conference | TVTX Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 15th International Podocyte Conference - Eagle-Tribune

Jun 11, 2025
pulisher
Jun 11, 2025

H.C. Wainwright Initiates Coverage on Travere Therapeutics (TVTX) with Optimistic Outlook | TVTX Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Travere Therapeutics (TVTX) Sees Price Target Adjustment with Ne - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Citi Adjusts Price Target and Maintains Buy Rating on Travere Therapeutics (TVTX) | TVTX Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Travere Therapeutics Clears Key Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily

Jun 11, 2025
pulisher
Jun 10, 2025

Travere Therapeutics Launches "Play It Forward" Campaign to Cele - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Grammy-Winning Producer Teams Up With Patient Artist for First-Ever FSGS Awareness Campaign - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

Travere Therapeutics, Inc. (NASDAQ:TVTX) Stake Boosted by California State Teachers Retirement System - Defense World

Jun 10, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Invests $583,000 in Travere Therapeutics, Inc. (NASDAQ:TVTX) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Sells 11,006 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Transcript : Travere Therapeutics, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 03 - marketscreener.com

Jun 06, 2025
pulisher
Jun 06, 2025

Travere Therapeutics, Inc. (NASDAQ:TVTX) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

IgA Nephropathy Market Forecast 2034: Clinical Trials, EMA, PDMA, FDA Approval, Treatment Market, Revenue, Statistics, Therapies, and Companies by DelveInsight - The Globe and Mail

Jun 06, 2025
pulisher
Jun 05, 2025

When (TVTX) Moves Investors should Listen - news.stocktradersdaily.com

Jun 05, 2025
pulisher
Jun 04, 2025

Travere Therapeutics, Inc. (TVTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 04, 2025
pulisher
Jun 04, 2025

Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 62nd ERA Congress - BioSpace

Jun 04, 2025
pulisher
Jun 03, 2025

Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 62nd ERA Congress | TVTX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Travere Therapeutics, Inc. (TVTX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 02, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Travere Therapeutics, Inc. (TVTX) And Encourages Shareholders to Connect - ACCESS Newswire

Jun 02, 2025
pulisher
Jun 01, 2025

2025-06-01 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Travere Therapeutics, Inc. (TVTX) And Encourages Shareholders to Reach Out | NDAQ:TVTX | Press Release - Stockhouse

Jun 01, 2025
pulisher
May 30, 2025

Levi & Korsinsky Launches Fraud Investigation on Behalf of Travere Therapeutics, Inc. (TVTX) Shareholders - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Travere Therapeutics, Inc. (TVTX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

May 30, 2025
pulisher
May 29, 2025

Would Travere Therapeutics (NASDAQ:TVTX) Be Better Off With Less Debt? - simplywall.st

May 29, 2025
pulisher
May 29, 2025

Lost Money on Travere Therapeutics, Inc. (TVTX)? Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

Travere Therapeutics, Inc. (TVTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

Travere Therapeutics, Inc. (NASDAQ:TVTX) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

May 29, 2025
pulisher
May 28, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Travere Therapeutics, Inc. (TVTX) And Encourages Investors to Connect - ACCESS Newswire

May 28, 2025
pulisher
May 28, 2025

TVTX Investor Notice: Levi & Korsinsky Investigates Travere Therapeutics, Inc. for Securities Law Violations - Louisiana First News

May 28, 2025
pulisher
May 27, 2025

FILSPARI to Transform Kidney Disease Care with Its Revolutionary Treatment Approach | DelveInsight - The Malaysian Reserve

May 27, 2025
pulisher
May 27, 2025

Travere Therapeutics, Inc. (NASDAQ:TVTX) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 27, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
大文字化:     |  ボリューム (24 時間):